Katherine A Donovan

@katherinedonovan.bsky.social

🇳🇿 Kiwi | Scientist | Targeted Protein Degradation | Chemoproteomics | Tweets are my own

Excited to share our discovery of potent TRIM21 molecular glues with anticancer activity, online today @CD_AACR: "Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex". 1/18

Bild

Heads up for those working in ubiquitin biology and targeted protein degradation—Lorne Ubiquitin 2025 is happening 20–23 November in Lorne, Victoria, Australia. Late abstracts are still being accepted—worth checking out if you’re looking to share your work in a focused, international setting. 🦘🦘🦘

Bild

We are looking to hire an Assistant/Associate Professor interested in creating an innovative (and exciting) program of research in chemical biology, medicinal chemistry, ML/AI, drug discovery - all in the context of cancer biology! careers.dana-farber.org/job/11813/as...

Faculty/Health Educator Job: Assistant/Associate Professor, Chemical Biology at Dana-Farber Cancer Institute in 450 Brookline Ave, Boston, MA

Assistant/Associate Professor, Chemical Biology job

careers.dana-farber.org

📢 Save the Date! The next FREE Dana-Farber TPD In-Person Event is coming soon! Join us for an afternoon of cutting-edge science, networking, and community building focused on Targeted Protein Degradation (TPD). Stay tuned for registration and speaker details.

Bild

Excited to be hosting next week’s DFCI TPD seminar! We’ll hear from two outstanding speakers, Rebecca Metivier and Martin Steger who will share their work on developing and applying mass spectrometry-based proteomics platforms to identify and catalog degrader targets. See you on May 15th @ 12PM EST

Bild

Excited to be sharing some of our recent work at the 2nd SMR molecular glues meeting

Society for Medicines Research@socmedres.bsky.social · 2y ago

🌟Speaker Spotlight: 2nd SMR Molecular Glues Meeting🌟 We are excited to welcome Dr Katherine Donovan @katherinedonovan.bsky.social from @danafarber.bsky.social as one of our distinguished speakers! 📅 21st March 2025 📍 GSK Stevenage, UK 🔗 lnkd.in/dNwWVtwE Join us at this exceptional event!

Join us for the final TPD webinar of 2024 on 12/19. @fleurmferguson.bsky.social & Eric Wang - "ZBTB11 Degraders Target Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC" Slava Ziegler - "Targeting IDO1 by monovalent degraders exploiting the native IDO1 degradation mechanism"

Bild

Through a series of cryo-EM structures, this study shows how an E2 and ubiquitin itself can play a "structural" role to specify ubiquitin linkage. 🧪 Lovely work by Katrina Warner, @moritzhunkeler.bsky.social @kheewoongbaek.bsky.social, @katherinedonovan.bsky.social and others in the Fischer Lab!

Milka Kostic@milkakostic.bsky.social · 2y ago

New #preprint - a amazing study of HECT ligase Tom1. This paper is a treat for those of you who LOVE #cryoEM and for those who love #ubiquitin! Congrats to the Fischer lab, including @moritzhunkeler.bsky.social and @ssroyburman.bsky.social who are on #bluesky. www.biorxiv.org/content/10.1...